Cyclacel Pharmaceuticals Inc


CYCC

Price

1.38


Change

-0.02


High

1.44


Low

1.34


Avg Volume

417,989


PE Ratio

NA


52 Week High

6.64


52 Week Low

1.05



Profile

Cyclacel Pharmaceuticals Inc. is a biotechnology firm based in Dundee, Scotland, and Short Hills, New Jersey, developing cancer drugs and treatments. Cyclacel was founded in 1996 by David Lane, Merlin Ventures and Cancer Research Campaign Technology with the University of Dundee and the University of Glasgow. Major shareholders include Goldman Sachs Group, Tang Capital Management, Redmile Group and Ayer Capital Management.


Top Streaming News


Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.

Data provided by IEX Cloud

About

Copyright © 2020 Finaza.IO. All Rights Reserved.